What is Delta 8 THC?
Delta-8-THC is growing in popularity across North America. But how is it different to its more famous cousin, Delta-9-THC? What are its effects? And is it, like many are claiming, federally legal in the US?
What Is Synthetic CBD?
As quality and safety regulations for the CBD industry are implemented, synthetic CBD is becoming an appealing alternative for the market, writes Richard O’Halloran, CEO of Biosportart.
New Mexico Legalizes Recreational Cannabis
During a legislative session on March 31, the state House and Senate both passed a legalization bill and a cannabis criminal record expungement bill.
New York Legalizes Recreational Cannabis
Lawmakers in New York have voted to legalize an adult-use cannabis market across the state.
AOAC Opens Call for Toxin Screening Methods in Cannabis Materials
AOAC International is now inviting submissions from cannabis laboratories with unique methods for mycotoxin screening and for the detection of Shiga toxin-producing Escherichia coli in cannabis plant materials and derivatives.
More Evidence Needed to Support Medical Cannabis Use for Pain, Say Experts
The International Association for the Study of Pain says it cannot currently endorse the general use of cannabis and cannabinoids for pain relief based on a lack of high-quality evidence.
FDA Issues Warning Letters to Two Companies Selling CBD Products for Pain Relief
California’s Honest Globe, Inc. and Michigan’s BioLyte Laboratories, LLC, have become the latest in a long line of companies to receive official warning letters from the FDA for the illegal marketing of unapproved CBD-containing drugs.
A Quarter of Parkinson’s Patients Have Tried Medical Cannabis, but It Doesn’t Always Work, Study Finds
The majority of people with Parkinson’s disease in the United States have not used cannabis to treat their symptoms due to a lack of scientific evidence about its effectiveness, the researchers found.
Could the “Spirit Molecule” DMT Assist in Stroke Recovery?
N,N-dimethyltryptamine (DMT) is a psychedelic compound under investigation for a range of therapeutic uses. One avenue of research is being pursued by Algernon Pharmaceuticals, who are investigating whether sub-hallucinogenic DMT doses could help to protect and repair the brain in the hours after a stroke.
